
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4682796
[patent_doc_number] => 20080249022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Antimicrobial Peptides Derived From Cap18'
[patent_app_type] => utility
[patent_app_number] => 11/658415
[patent_app_country] => US
[patent_app_date] => 2005-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11622
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658415 | Antimicrobial peptides derived from CAP18 | Jul 25, 2005 | Issued |
Array
(
[id] => 81169
[patent_doc_number] => 07745123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Cell cycle reporting cell line'
[patent_app_type] => utility
[patent_app_number] => 11/572516
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3187
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11572516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572516 | Cell cycle reporting cell line | Jul 21, 2005 | Issued |
Array
(
[id] => 4507597
[patent_doc_number] => 07915218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-29
[patent_title] => 'Polypeptides for oligomeric assembly of antigens'
[patent_app_type] => utility
[patent_app_number] => 11/632385
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 15451
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/915/07915218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632385 | Polypeptides for oligomeric assembly of antigens | Jul 21, 2005 | Issued |
Array
(
[id] => 5241727
[patent_doc_number] => 20070020219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Method for promoting hair growth'
[patent_app_type] => utility
[patent_app_number] => 11/187394
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3549
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020219.pdf
[firstpage_image] =>[orig_patent_app_number] => 11187394
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/187394 | Method for promoting hair growth | Jul 20, 2005 | Issued |
Array
(
[id] => 522145
[patent_doc_number] => 07186685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Compositions comprising gelatin-glycine and carotenoids'
[patent_app_type] => utility
[patent_app_number] => 11/177500
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4281
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177500 | Compositions comprising gelatin-glycine and carotenoids | Jul 10, 2005 | Issued |
Array
(
[id] => 5807683
[patent_doc_number] => 20060094037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Proteins related to schizophrenia and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/170482
[patent_app_country] => US
[patent_app_date] => 2005-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19948
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11170482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/170482 | Proteins related to schizophrenia and uses thereof | Jun 27, 2005 | Abandoned |
Array
(
[id] => 5771582
[patent_doc_number] => 20050267033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Multi-dose erythropoietin formulations'
[patent_app_type] => utility
[patent_app_number] => 11/167818
[patent_app_country] => US
[patent_app_date] => 2005-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5593
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11167818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/167818 | Multi-dose erythropoietin formulations | Jun 26, 2005 | Issued |
Array
(
[id] => 5710050
[patent_doc_number] => 20060051395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants'
[patent_app_type] => utility
[patent_app_number] => 11/152974
[patent_app_country] => US
[patent_app_date] => 2005-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15097
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11152974
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/152974 | IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants | Jun 14, 2005 | Issued |
Array
(
[id] => 6926452
[patent_doc_number] => 20050239708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis'
[patent_app_type] => utility
[patent_app_number] => 11/152468
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12746
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11152468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/152468 | Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis | Jun 13, 2005 | Abandoned |
Array
(
[id] => 5769042
[patent_doc_number] => 20060019892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Conopeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/149757
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19315
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149757 | Conopeptides and methods of use | Jun 9, 2005 | Abandoned |
Array
(
[id] => 925700
[patent_doc_number] => 07316998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Cerberus/Coco derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/140024
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 15209
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140024 | Cerberus/Coco derivatives and uses thereof | May 26, 2005 | Issued |
Array
(
[id] => 567210
[patent_doc_number] => 07462476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Methods for large scale production of recombinant DNA-derived tPA or K2S molecules'
[patent_app_type] => utility
[patent_app_number] => 11/134385
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 8949
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134385 | Methods for large scale production of recombinant DNA-derived tPA or K2S molecules | May 22, 2005 | Issued |
Array
(
[id] => 151486
[patent_doc_number] => 07678544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'ADAM12, a novel marker for abnormal cell function'
[patent_app_type] => utility
[patent_app_number] => 11/131952
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 21481
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131952 | ADAM12, a novel marker for abnormal cell function | May 17, 2005 | Issued |
Array
(
[id] => 4903992
[patent_doc_number] => 20080113405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Gene-Cassette For Enhancement Of Protein Production'
[patent_app_type] => utility
[patent_app_number] => 11/579419
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8006
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579419 | Gene-Cassette For Enhancement Of Protein Production | May 16, 2005 | Abandoned |
Array
(
[id] => 5279178
[patent_doc_number] => 20090131310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Mucin3 egf-like domains'
[patent_app_type] => utility
[patent_app_number] => 11/596273
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9710
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596273
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596273 | Mucin3 egf-like domains | May 12, 2005 | Abandoned |
Array
(
[id] => 8559932
[patent_doc_number] => 08333995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-18
[patent_title] => 'Protein microspheres having injectable properties at high concentrations'
[patent_app_type] => utility
[patent_app_number] => 11/127704
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 52
[patent_no_of_words] => 19379
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11127704
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127704 | Protein microspheres having injectable properties at high concentrations | May 11, 2005 | Issued |
Array
(
[id] => 5715202
[patent_doc_number] => 20060078565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Nucleic acids and proteins from Group B Streptococcus'
[patent_app_type] => utility
[patent_app_number] => 11/123241
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 14350
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123241
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123241 | Nucleic acids and proteins from Group B Streptococcus | May 5, 2005 | Abandoned |
Array
(
[id] => 613005
[patent_doc_number] => 07148404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Antimicrobial polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/119581
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20621
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148404.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119581 | Antimicrobial polypeptides | May 1, 2005 | Issued |
Array
(
[id] => 7057621
[patent_doc_number] => 20050278796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'FIAT nucleic acids and proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/118809
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 26878
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20050278796.pdf
[firstpage_image] =>[orig_patent_app_number] => 11118809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/118809 | FIAT nucleic acids and proteins and uses thereof | Apr 28, 2005 | Issued |
Array
(
[id] => 152197
[patent_doc_number] => 07678888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/593387
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2908
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593387 | Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof | Apr 19, 2005 | Issued |